(Q61975946)

English

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

An Open, Single Center Trial to Evaluate the Efficacy and Safety of Dose Escalation of Icotinib in Advanced NSCLC Patients After TKI Therapy (English)
0 references
February 2014
0 references
December 2018
0 references
30
0 references
18 year
0 references
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit